Lifebit Provides Free Cloud, Data Hosting & Analysis Tools to COVID-19 Researchers

Today Lifebit Biotech announced it is providing its premium Lifebit CloudOS license free to all researchers and teams working on COVID-19 efforts, including diagnostics, treatments, and vaccines. As increasing demand for widely accessible reference data and massive data sharing has never been more apparent, this initiative provides researchers with a seamless way to perform their analyses securely, while enabling teams to freely collaborate even when working from home.

Sano Genetics Deploys Lifebit CloudOS for Direct-to-Consumer Genetics

Today Sano Genetics announced the company is using Lifebit CloudOS to power their free DNA sequencing platform, achieving 35% increase in speed of imputation analyses. Imputation is a statistical technique that fills in the gaps between sites measured by genotyping arrays, and is very useful for genetic genealogy and other forms of ‘citizen science’. Any participant who uploads their DTC genetic data to the Sano platform can download their imputed data within about 15 minutes.

Lifebit Launches Federated Genomics Cloud Operating System

Today Lifebit Biotech announced the general release of Lifebit CloudOS. The fully federated, cloud-native system is designed for companies in the pharmaceutical, drug discovery, direct-to-consumer genetics, healthcare, and population genomics industries. “Because it is completely agnostic to the customer’s HPC and cloud infrastructure, workflows and data, Lifebit CloudOS is unlike any other genomics platforms in that it sits natively on one’s cloud/HPC and brings computation to the data instead of the other way around. This is a game-changer for organizations in genomics fields where data is too big to move and security and compliance are absolutely paramount.”

Lifebit Launches Federated Genomics Cloud Operating System for Accelerated Discovery

Lifebit CloudOS solves the major barrier faced by the genomics sector: data is often siloed and distributed, inaccessible for multiple parties to analyze. Without the ability to perform analyses across this distributed data the industry is stalled, impeding critical progress in precision medicine and life sciences. “Because it is completely agnostic to the customer’s HPC and cloud infrastructure, workflows and data, Lifebit CloudOS is unlike any other genomics platforms in that it sits natively on one’s cloud/HPC and brings computation to the data instead of the other way around.”